Learning Opportunity on Use of Monoclonal Antibody Therapies for COVID-19

LeadingAge, AHCA, and AMDA are jointly collaborating with the federal COVID response team to hold a live event, “Update on the Use of Monoclonal Antibody (mAB) Therapies for COVID-19: A Review of New Treatments and At-Risk Populations.” The event is set for June 15 at 2 p.m. CDT.

Dr. Michael Anderson of the federal COVID response team will present an overview, followed by a panel with a representative from each of the three associations discussing experiences, obstacles, and opportunities with mAB.

Register here for the event.  If you cannot attend the live webinar, registrants will be notified when the recording is made available.

For additional information about monoclonal antibodies, see this MDH webpage.

Back to news home »

Previous DHS Hosts June 17 Community Forum on Racial and Ethnic Disparities in HCBS


No one has commented on this article yet. Please post a comment below.

Add a comment

Members must sign in to comment

You must be a member to comment on this article. If you are already a member, please log in. Not a member? Learn how to join »

Log In